Journal of Rheumatic Diseases

Cited by CrossRef (4)

  1. Sandeep Yadav, Vishnu Sharma, C. Balakrishnan. Tocilizumab Therapy for Treatment-Resistant Systemic Lupus Erythematosus with Elevated IL-6 and CRP Levels: a Case Report. SN Compr. Clin. Med. 2023;5
    https://doi.org/10.1007/s42399-023-01543-8
  2. Ju-Yang Jung, Moon-Young Kim, Chang-Hee Suh, Hyoun-Ah Kim. Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review. Pediatr Rheumatol 2018;16
    https://doi.org/10.1186/s12969-018-0296-z
  3. Luca Antonini, Brigitte Le Mauff, Christian Marcelli, Achille Aouba, Hubert de Boysson. Rhupus: a systematic literature review. Autoimmunity Reviews 2020;19:102612
    https://doi.org/10.1016/j.autrev.2020.102612
  4. N. Yu. Nikishina, E. A. Aseeva, A. A. Mesnyankina, S. K. Soloviev. Rhupus – a combination of systemic lupus erythematosus and rheumatoid arthritis as a separate disease phenotype (a clinical case). Sovremennaâ revmatologiâ 2023;17:65
    https://doi.org/10.14412/1996-7012-2023-2-65-71